Project: The development of an accurate host genetic diagnostic assay for women with subfertility.
Almost 25% of women with Chlamydia t. (CT)-associated subfertility are faced with sub-optimal treatments due to a lack of accurate diagnostic tools. Genetic studies have enabled the discovery of 50 single nucleotide polymorphisms (SNP) and their validation as subfertility biomarkers. TUBATEST has been designed to develop a diagnostic assay based on host genetic SNP profiling. TUBATEST will enable the accurate diagnosis of women with CT-associated subfertility, thereby improving their health.
| Acronym | TUBATEST (Reference Number: 9372) |
| Duration | 01/07/2015 - 01/03/2019 |
| Project Topic | Biological Sciences / Technologies |
| Network | Eurostars 2 |
| Call | Eurostars Cut-Off 2 |
Project partner
| Number | Name | Role | Country |
|---|---|---|---|
| 20452 | TubaScan Ltd. | Coordinator | Netherlands |
| 20453 | Delta Diagnostics trading as Elucigene Diagnostics | Partner | United Kingdom |
| 20454 | ClinicaGeno Limited | Partner | United Kingdom |
| 20455 | University Medical Centre Groningen | Partner | Netherlands |
| 20456 | Maastricht University Medical Centre | Partner | Netherlands |
| 20457 | Uppsala University | Partner | Sweden |